NETCORE-CLOUD
30.3.2022 11:32:11 CEST | Business Wire | Press release
Netcore Cloud , a profitable SaaS company and global leader in customer communication, engagement, and retention, bets big on Personalization with its investment of close to $100 mn to acquire a majority stake in US-based, search-personalization company Unbxd Inc. It will also be infusing additional funding into Unbxd to propel the company's growth in developed markets.
Founded by Pavan Sondur and Prashant Kumar in 2012, Unbxd is a 120-member team and has built a best-in-class AI-powered Product Discovery suite. Its intelligent search solutions significantly improve retention and conversions for leading eCommerce retailers/B2C brands in the USA, UK, and Australia, including marquee brands like Mattress Firm, Express, Ashley Homestore, Home Shopping Network, Advance Auto Parts, The Children's Place, Mitre10, Kookai, and many others.
Netcore Cloud, has ranked a strong performer globally in email marketing by Forresterwave, commands 75% of India's & 50% of Asia's email traffic on its platform. With Unbxd's expertise in product discovery, the investment positions Netcore Cloud's as a leading Digital Experience Platform (DXP) globally. Leveraging Unbxd's AI-powered search expertise equips Netcore Cloud to deliver a real-time recommendation to its online eCommerce/app-first brand and retailer.
"The coming MarTech era will be defined by budget shifts from Adtech to MarTech as brands will focus more on unit economics and valuing existing customers. This will lead D2C/eCommerce brands to accelerate their spending towards delivering personalized customer experiences. Unbxd's AI/ML tech stack will empower our customers to track their shopper’s interactions with Search and implement site-wide Personalization, merchandising, along with shopper-focused recommendations. This will enable brands to optimize their entire customer journey, providing the best in class customer experience," said Kalpit Jain, Group CEO, Netcore Cloud.
"Netcore Cloud platform is growing rapidly at 40% YoY (with international markets growing 100% YoY ). We are positioned as the digital proxy in emerging markets. Added to that, this investment will enable us to get a strong foothold in the US and other developed markets as well. Furthermore, the combination of Unbxd and Netcore Cloud's capabilities will bolster our full-stack product offerings,” said Nishant Jain, Chief Strategy Officer and Head of M&A, Netcore Cloud.
He further added, “The SaaS market is very fragmented, and the era of SaaS consolidation is upon us. We intend to fast-track our growth exponentially with the Buy-Partner strategy. This is our fourth acquisition in quick succession, and we already have our eyes set on the next one.”
Pavan Sondur and Prashant, Co-founders at Unbxd, said, "Since our launch, we at Unbxd have been on a mission to solve the problem of discovery for digital commerce leveraging the power of AI. With our unique combination of personalization solutions and Netcore's robust full-stack marketing automation tech platform, it's a perfect partnership that can capture cross-selling opportunities and scale the business globally.
Netcore Cloud has confirmed that there will be no change in the company's management, as the founders and key management will continue to build and grow the company post this deal. Unbxd will operate as an independent entity.
About Netcore Cloud:
Netcore Cloud is a bootstrapped SaaS company that helps B2C brands and marketers create AI-powered new-age customer experiences at every touchpoint of a customer's journey. Netcore Cloud's full-stack marketing platform enables highly personalized digital experiences that are easily scalable and provide actionable analytics, real-time reporting, and quick to implement solutions across channels. Brands using Netcore Cloud can have a unified view of their customers and optimize their user experience.
Headquartered in Mumbai, India, with 11 offices across the USA, Singapore, Malaysia, Nigeria, Indonesia, UAE, UK, and Germany, Netcore Cloud serves 5000+ customers across the globe. It delivers 17+ billion emails and tracks 100+ billion marketing events every month. Netcore Cloud is a trusted partner across industries with some of the most respected brands like MaxLife Insurance, ICICI Bank, Standard Chartered, Flipkart, Myntra, Miss Amara, Airtel, Disney Hotstar, Canon, Puma, Tobi, EaseMyTrip, PizzaHut and McDonald's. For more information, visit https://netcorecloud.com/
About Unbxd:
Unbxd is an eCommerce product discovery platform to help online retailers provide a seamless shopping experience to customers. The company deploys self-learning AI/ML models and advanced algorithms to deliver personal recommendation and merchandising controls. Presently, the company empowers 3.5% of all US e-commerce on-site search queries spread over 150+ customers. The company has a wide presence in 40+ countries and provides intelligent site search to more than 1,200 eCommerce sites.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220328005966/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom